Institution
American Cancer Society
Nonprofit•Atlanta, Georgia, United States•
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.
Papers published on a yearly basis
Papers
More filters
••
Thomas Jefferson University1, Louisiana State University2, NorthShore University HealthSystem3, University of Chicago4, Washington University in St. Louis5, University of Minnesota6, Johns Hopkins University7, University of Washington8, Emory University9, Harvard University10, Eli Lilly and Company11, LSU Health Sciences Center Shreveport12, Memorial Sloan Kettering Cancer Center13, Duke University14, University of California, San Francisco15, University of Virginia16, American Cancer Society17
TL;DR: Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening as mentioned in this paper, which recommends that clinicians with access to high-volume, high-quality screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years.
Abstract: Findings from the National Cancer Institute’s National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30–pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation. CA Cancer J Clin 2013;000:000-000. V C 2013 American Cancer Society.
635 citations
••
TL;DR: Hispanics/Latinos are the largest and fastest growing major demographic group in the United States, accounting for 16.3% (50.5 million/310 million) of the US population in 2010 and have lower incidence and death rates than non‐Hispanic whites for all cancers combined and for the 4 most common cancers.
Abstract: Hispanics/Latinos are the largest and fastest growing major demographic group in the United States, accounting for 16.3% (50.5 million/310 million) of the US population in 2010. In this article, the American Cancer Society updates a previous report on cancer statistics for Hispanics using incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. In 2012, an estimated 112,800 new cases of cancer will be diagnosed and 33,200 cancer deaths will occur among Hispanics. In 2009, the most recent year for which actual data are available, cancer surpassed heart disease as the leading cause of death among Hispanics. Among US Hispanics during the past 10 years of available data (2000-2009), cancer incidence rates declined by 1.7% per year among men and 0.3% per year among women, while cancer death rates declined by 2.3% per year in men and 1.4% per year in women. Hispanics have lower incidence and death rates than non-Hispanic whites for all cancers combined and for the 4 most common cancers (breast, prostate, lung and bronchus, and colorectum). However, Hispanics have higher incidence and mortality rates for cancers of the stomach, liver, uterine cervix, and gallbladder, reflecting greater exposure to cancer-causing infectious agents, lower rates of screening for cervical cancer, differences in lifestyle and dietary patterns, and possibly genetic factors. Strategies for reducing cancer risk among Hispanics include increasing utilization of screening and available vaccines, as well as implementing effective interventions to reduce obesity, alcohol consumption, and tobacco use.
634 citations
••
American Cancer Society1, University of Washington2, University of Arkansas for Medical Sciences3, The Royal Marsden NHS Foundation Trust4, University of Washington Medical Center5, Memorial Sloan Kettering Cancer Center6, University of North Carolina at Chapel Hill7, University of Pennsylvania8, Northwestern University9, University of Toronto10, Sunnybrook Health Sciences Centre11, University of Southern California12
TL;DR: The American Cancer Society (ACS) found that nonconventional screening measures such as magnetic resonance imaging (MRI) might be suitable for women at increased risk of breast cancer, but there was not enough evidence to warrant making recommendations as mentioned in this paper.
Abstract: The American Cancer Society (ACS), in 2003, found that nonconventional screening measures such as magnetic resonance imaging (MRI) might be suitable for women at increased risk of breast cancer, but there was not enough evidence to warrant making recommendations. Since then, more information
619 citations
••
TL;DR: No precise estimate can be made of the number of deaths attributable to smoking in undeveloped countries, but the prevalence of smoking suggests that it will be large, rising to 10 million a year in 30-40 years' time.
Abstract: Estimates are made of the numbers and proportions of deaths attributable to smoking in 44 developed countries in 1990. In developed countries as a whole, tobacco was responsible for 24% of all male deaths and 7% of all female deaths, rising to over 40% in men in some former socialist economies and 17% in women in the USA. The average loss of life for all cigarette smokers was about 8 years and for those whose deaths were attributable to tobacco about 16 years. Trends in mortality attributable to tobacco differed between countries. In some the mortality in middle age (35-69 years) had decreased by half in men since 1965; in others it was continuing to increase. In women, the proportion was mostly increasing, almost universally in old age. Mortality not attributable to smoking decreased since 1955 in all OECD (Organization for European Collaboration and Development) countries, by up to 60% in men and more in women. No precise estimate can be made of the number of deaths attributable to smoking in undeveloped countries, but the prevalence of smoking suggests that it will be large. In the world as a whole, some 3 million deaths a year are estimated to be attributable to smoking, rising to 10 million a year in 30-40 years' time.
614 citations
••
University of Southern California1, National Institutes of Health2, Memorial Sloan Kettering Cancer Center3, University of Massachusetts Amherst4, Yale University5, Karolinska Institutet6, University of Washington7, Maastricht University8, University of Pennsylvania9, QIMR Berghofer Medical Research Institute10, Vanderbilt University11, University of Minnesota12, Roswell Park Cancer Institute13, University of Toronto14, American Cancer Society15, University of South Florida16, Curie Institute17, City of Hope National Medical Center18, Alberta Health Services19, University at Buffalo20, Dartmouth College21, Harvard University22, University of Alberta23, University of New Mexico24, Fred Hutchinson Cancer Research Center25, University of California, Irvine26, Cancer Prevention Institute of California27
TL;DR: The results of this pooled analysis suggest that the two endometrial cancer types share many common etiologic factors, and the etiology of type II tumors may, therefore, not be completely estrogen independent, as previously believed.
Abstract: Purpose Endometrial cancers have long been divided into estrogen-dependent type I and the less common clinically aggressive estrogen-independent type II. Little is known about risk factors for type II tumors because most studies lack sufficient cases to study these much less common tumors separately. We examined whether so-called classical endometrial cancer risk factors also influence the risk of type II tumors. Patients and Methods Individual-level data from 10 cohort and 14 case-control studies from the Epidemiology of Endometrial Cancer Consortium were pooled. A total of 14,069 endometrial cancer cases and 35,312 controls were included. We classified endometrioid (n = 7,246), adenocarcinoma not otherwise specified (n = 4,830), and adenocarcinoma with squamous differentiation (n = 777) as type I tumors and serous (n = 508) and mixed cell (n = 346) as type II tumors. Results Parity, oral contraceptive use, cigarette smoking, age at menarche, and diabetes were associated with type I and type II tumors to...
599 citations
Authors
Showing all 1345 results
Name | H-index | Papers | Citations |
---|---|---|---|
Walter C. Willett | 334 | 2399 | 413322 |
Meir J. Stampfer | 277 | 1414 | 283776 |
Frank B. Hu | 250 | 1675 | 253464 |
David J. Hunter | 213 | 1836 | 207050 |
Edward Giovannucci | 206 | 1671 | 179875 |
Irving L. Weissman | 201 | 1141 | 172504 |
Bernard Rosner | 190 | 1162 | 147661 |
Susan E. Hankinson | 151 | 789 | 88297 |
Paolo Boffetta | 148 | 1455 | 93876 |
Jeffrey A. Bluestone | 143 | 515 | 77080 |
Richard D. Smith | 140 | 1180 | 79758 |
Garth D. Illingworth | 137 | 505 | 61793 |
Brian E. Henderson | 137 | 712 | 69921 |
Ahmedin Jemal | 132 | 500 | 380474 |
Michael J. Thun | 129 | 392 | 79051 |